Abstract:Cryptotanshinone (CTS), a major constituent from the roots of Salvia miltiorrhiza (Danshen), is widely used in the treatment of coronary heart disease, stroke and less commonly Alzheimer's disease. Our recent study indicates that CTS is a substrate for P-glycoprotein (PgP/MDR1/ABCB1). This study has investigated the nature of the brain distribution of CTS across the brain-blood barrier (BBB) using several in vitro and in vivo rodent models. A polarized transport of CTS was found in rat primary microvascular endothelial cell (RBMVEC) monolayers, with facilitated efflux from the abluminal side to luminal side. Addition of a PgP (e.g. verapamil and quinidine) or multi-drug resistance protein 1/2 (MRP1/2) inhibitor (e.g. probenecid and MK-571) in both luminal and abluminal sides attenuated the polarized transport. In a bilateral in situ brain perfusion model, the uptake of CTS into the cerebrum increased from 0.52 +/- 0.1% at 1 min to 11.13 +/- 2.36 ml/100 g tissue at 30 min and was significantly greater than that of sucrose. Co-perfusion of a PgP/MDR1 (e.g. verapamil) or MRP1/2 inhibitor (e.g. probenecid) significantly increased the brain distribution of CTS by 35.1-163.6%. The brain levels of CTS were only about 21% of those in plasma, and were significantly increased when coadministered with verapamil or probenecid in rats. The brain levels of CTS in rats subjected to middle cerebral artery occlusion and rats treated with quinolinic acid (a neurotoxin) were about 2- to 2.5-fold higher than the control rats. Moreover, the brain levels in mdr1a(-/-) and mrp1(-/-) mice were 10.9- and 1.5-fold higher than those in the wild-type mice, respectively. Taken collectively, these findings indicate that PgP and Mrp1 limit the brain penetration of CTS in rodents, suggesting a possible role of PgP and MRP1 in limiting the brain penetration of CTS in patients and causing drug resistance to Danshen therapy and interactions with conventional drugs that are substrates of PgP and MRP1. Further studies are needed to explore the role of other drug transporters in restricting the brain penetration of CTS and the clinical relevance.

Transportation of the enantiomers of trans tramadol and 0-demethyltramadol across blood-brain barrier

Distribution of Enantiomers of Trans-Tramadol and Trans-O-demethyltramadol in Central Nervous System of Rats.

Pharmacokinetics of Enantiomers of Trans-Tramadol and Its Active Metabolite, Trans-O-demethyltramadol, in Human Subjects.

[Stereoselectivity in Biliary Excretion of Trans Tramadol and Trans O-demethyltramadol in Rats].

Stereoselectivity in Trans-Tramadol Metabolism and Trans-O-demethyltramadol Formation in Rat Liver Microsomes.

Pharmacokinetics of the enantiomers of trans-tramadol and its active metabolite, trans-O-demethyltramadol, in healthy male and female chinese volunteers.

Gender-related differences in pharmacokinetics of enantiomers of trans-tramadol and its active metabolite, trans-O-demethyltramadol, in rats

STEREOSELECTIVITY IN PHARMACOKINETICS OF THE ENANTIOMERS OF TRANS TRAMADOL

[Stereoselectivity in Absorption of Trans Tramadol in Rat Intestine].

Stereoselectivity in renal clearance of trans-tramadol and its active metabolite, trans-O-demethyltramadol.

[Gender-Related Differences in Metabolism of the Enantiomers of Trans Tramadol and Trans O-demethyltramadol in Rat Liver Microsomes].

Uptake/efflux transport of tramadol enantiomers and O-desmethyl-tramadol: focus on P-glycoprotein

[Stereoselectivity in O-demethylation of Trans Tramadol in Rat Liver Microsomes in Vitro].

Brain Pharmacokinetics and Tissue Distribution of Tetrahydropalmatine Enantiomers in Rats after Oral Administration of the Racemate

Stereoselective Metabolism of Tetrahydropalmatine Enantiomers in Rat Liver Microsomes

Transport of Cryptotanshinone, a Major Active Triterpenoid in Salvia Miltiorrhiza Bunge Widely Used in the Treatment of Stroke and Alzheimers Disease, Across the Blood-Brain Barrier

Regulation of Cerebral CYP2D Alters Tramadol Metabolism in the Brain: Interactions of Tramadol with Propranolol and Nicotine.

Role of P-glycoprotein in Restricting the Brain Penetration of Tanshinone IIA, a Major Active Constituent from the Root of Salvia Miltiorrhiza Bunge, Across the Blood–brain Barrier

The two enantiomers of tetrahydropalmatine are inhibitors of P-gp, but not inhibitors of MRP1 or BCRP

Determination of the Enantioselectivity of Six Chiral Aryloxy Aminopropanol Drugs Transport Across Caco-2 Cell Monolayers

Sex hormones regulate cerebral drug metabolism via brain miRNAs: down‐regulation of brain CYP2D by androgens reduces the analgesic effects of tramadol